Cargando…

In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer’s disease

BACKGROUND: We investigated regional amyloid staging characteristics in (11)C-PiB-PET data from middle-aged to older participants at elevated risk for AD enrolled in the Wisconsin Registry for Alzheimer’s Prevention. METHODS: We analyzed partial volume effect-corrected (11)C-PiB-PET distribution vol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Levin, Fedor, Jelistratova, Irina, Betthauser, Tobey J., Okonkwo, Ozioma, Johnson, Sterling C., Teipel, Stefan J., Grothe, Michel J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532333/ https://www.ncbi.nlm.nih.gov/pubmed/34674764 http://dx.doi.org/10.1186/s13195-021-00918-0

Ejemplares similares

Longitudinal validity of PET‐based staging of regional amyloid deposition
por: Jelistratova, Irina, et al.
Publicado: (2020)

Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer’s Disease
por: Mueller, Kimberly D., et al.
Publicado: (2022)

Molecular properties underlying regional vulnerability to Alzheimer’s disease pathology
por: Grothe, Michel J, et al.
Publicado: (2018)

An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum
por: Van Hulle, Carol, et al.
Publicado: (2020)

Association of PET‐based stages of amyloid deposition with neuropathological markers of Aβ pathology
por: Teipel, Stefan J., et al.
Publicado: (2020)

Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
por: Langhough Koscik, Rebecca, et al.
Publicado: (2021)

Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2019)

Correction: Applicability of in vivo staging of regional amyloid burden in a cognitively normal cohort with subjective memory complaints: the INSIGHT-preAD study
por: Sakr, Fatemah A., et al.
Publicado: (2022)

In vivo staging of regional amyloid deposition
por: Grothe, Michel J., et al.
Publicado: (2017)

Crosswalk study on blood collection‐tube types for Alzheimer's disease biomarkers
por: Jonaitis, Erin M., et al.
Publicado: (2022)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age
por: Betthauser, Tobey J, et al.
Publicado: (2020)

Amyloid beta associations with connected speech in cognitively unimpaired adults
por: Mueller, Kimberly D., et al.
Publicado: (2021)

The relationship of insulin resistance and diabetes to tau PET SUVR in middle-aged to older adults
por: Ennis, Gilda E., et al.
Publicado: (2023)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention
por: Cody, Karly A., et al.
Publicado: (2022)

Amyloid accumulation in Down syndrome measured with amyloid load
por: Zammit, Matthew D., et al.
Publicado: (2020)

Associations between self-reported sleep patterns and health, cognition and amyloid measures: results from the Wisconsin Registry for Alzheimer’s Prevention
por: Du, Lianlian, et al.
Publicado: (2023)

Cerebrovascular stiffness and flow dynamics in the presence of amyloid and tau biomarkers
por: Rivera‐Rivera, Leonardo A., et al.
Publicado: (2021)

Imaging neurodegeneration in Down syndrome: brain templates for amyloid burden and tissue segmentation
por: Lao, Patrick J., et al.
Publicado: (2018)

Neuropathologic features associated with basal forebrain atrophy in Alzheimer disease
por: Teipel, Stefan J., et al.
Publicado: (2020)

Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology
por: Tanabe, Sean, et al.
Publicado: (2020)

White matter microstructure in late middle-age: Effects of apolipoprotein E4 and parental family history of Alzheimer's disease
por: Adluru, Nagesh, et al.
Publicado: (2014)

Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
por: Erickson, Pontus, et al.
Publicado: (2023)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

Trajectory of clinical symptoms in relation to amyloid chronicity
por: Birdsill, Alex C., et al.
Publicado: (2022)

Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention
por: Doherty, Benjamin M., et al.
Publicado: (2015)

Cardiorespiratory fitness mitigates brain atrophy and cognitive decline in adults at risk for Alzheimer's disease
por: Dougherty, Ryan J., et al.
Publicado: (2021)

No association of cortical amyloid load and EEG connectivity in older people with subjective memory complaints
por: Teipel, Stefan, et al.
Publicado: (2017)

A fresh look at the multi‐level social determinants of disparities in Alzheimer's disease and related dementias
por: Britton, Gabrielle B., et al.
Publicado: (2023)

Sex differences in off-target binding using tau positron emission tomography
por: Smith, Ruben, et al.
Publicado: (2021)

The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment — Beyond classical regression
por: Teipel, Stefan J., et al.
Publicado: (2015)

Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors
por: Teipel, Stefan J., et al.
Publicado: (2018)

Erythrocyte sphingolipid species as biomarkers of Alzheimer's disease
por: Mill, Jericha, et al.
Publicado: (2022)

Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction
por: Henf, Judith, et al.
Publicado: (2017)

Amyloid duration is associated with preclinical cognitive decline and tau PET
por: Koscik, Rebecca L., et al.
Publicado: (2020)

Effects of Aerobic Exercise Training on Systemic Biomarkers and Cognition in Late Middle-Aged Adults at Risk for Alzheimer’s Disease
por: Gaitán, Julian M., et al.
Publicado: (2021)

Multi-method investigation of factors influencing amyloid onset and impairment in three cohorts
por: Betthauser, Tobey J, et al.
Publicado: (2022)

Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation
por: Racine, Annie M., et al.
Publicado: (2014)

Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease
por: Dyrba, Martin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v346oqeh30hi09g26dnf4igdtq